August 2008


Shares of BioDelivery Sciences International soared for a second straight day Friday, the day after the company announced positive news about its lead experimental drug.

GTx Inc. CEO Mitchell Steiner will ring Nasdaq’s opening bell on Tuesday, Sept. 2.

Claes Wahlestedt, who heads Scripps Florida’s efforts to develop drugs for diseases of the central nervous system, has launched new company with business consultant and longtime friend Joe Collard.

A Mylan Inc. subsidiary will immediately release a generic version of the Alzheimer’s disease drug Razadyne after it won a patent challenge and received regulatory approval, the Canonsburg-based drugmaker said. (MYL)

A day after it halted clinical trials on its prostate cancer drug and saw its stock plummet 72 percent, Cell Genesys Inc. got a hint of relief. (CEGE)

Next Page »

Web Optimization - Body Health - Honda Civic - Serbia Phone Cards - Hartz Iv